| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1001690698 |
| P356 | DOI | 10.1038/LEU.2011.35 |
| P8608 | Fatcat ID | release_2dpoltc5xzegzitwbvs5fr5vly |
| P932 | PMC publication ID | 3115054 |
| P698 | PubMed publication ID | 21394098 |
| P5875 | ResearchGate publication ID | 50364461 |
| P2093 | author name string | M G Masucci | |
| S A Kamranvar | |||
| P2860 | cites work | Mammalian telomeres end in a large duplex loop | Q22009893 |
| Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex. | Q24298041 | ||
| In vivo stoichiometry of shelterin components | Q24312021 | ||
| Control of telomere length by the human telomeric protein TRF1 | Q24320111 | ||
| Telomere elongation in immortal human cells without detectable telomerase activity | Q24598626 | ||
| Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2 | Q24793970 | ||
| TRF2 Protects Human Telomeres from End-to-End Fusions | Q28111898 | ||
| Cell cycle dependent localization of the telomeric PARP, tankyrase, to nuclear pore complexes and centrosomes | Q28145946 | ||
| Shelterin: the protein complex that shapes and safeguards human telomeres | Q28272546 | ||
| Senescence Induced by Altered Telomere State, Not Telomere Loss | Q28315731 | ||
| Telomere dysfunction and evolution of intestinal carcinoma in mice and humans | Q28504673 | ||
| Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice | Q28594944 | ||
| DNA damage foci at dysfunctional telomeres | Q29614811 | ||
| A survey of telomerase activity in human cancer | Q29614858 | ||
| A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes | Q29617061 | ||
| Epstein-Barr virus: 40 years on | Q29617969 | ||
| Protection of mammalian telomeres | Q29618391 | ||
| Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres | Q33250125 | ||
| Reconsideration of senescence, immortalization and telomere maintenance of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines | Q33591008 | ||
| EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3 | Q33793531 | ||
| Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice | Q33914498 | ||
| Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells | Q33968413 | ||
| Telomere length maintenance in aging and carcinogenesis. | Q34058741 | ||
| DNA damage-induced phosphorylation of the human telomere-associated protein TRF2. | Q34098695 | ||
| Epstein-Barr virus and oncogenesis: from latent genes to tumours | Q34221194 | ||
| Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes | Q35080523 | ||
| Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes | Q36633820 | ||
| Telomere uncapping and alternative lengthening of telomeres | Q37063680 | ||
| The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. | Q37114836 | ||
| Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers. | Q37764530 | ||
| Epstein-Barr virus promotes genomic instability in Burkitt's lymphoma | Q40165999 | ||
| Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cell lines | Q40403799 | ||
| Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. | Q40571053 | ||
| Telomere maintenance by telomerase and by recombination can coexist in human cells | Q40780754 | ||
| Telomere maintenance by recombination in human cells. | Q40839283 | ||
| Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening | Q41121125 | ||
| Identification of ROS using oxidized DCFDA and flow-cytometry. | Q43194927 | ||
| Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication | Q45733048 | ||
| DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA. | Q53538631 | ||
| Chromosomal rearrangements after ex vivo Epstein–Barr virus (EBV) infection of human B cells | Q61718416 | ||
| A role for both RB and p53 in the regulation of human cellular senescence | Q64378339 | ||
| Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines | Q73851376 | ||
| Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body | Q78257210 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 1017-1025 | |
| P577 | publication date | 2011-03-11 | |
| P1433 | published in | Leukemia | Q6534498 |
| P1476 | title | The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress | |
| P478 | volume | 25 |
| Q39084230 | A high-yielding CHO transient system: coexpression of genes encoding EBNA-1 and GS enhances transient protein expression |
| Q34385189 | ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53. |
| Q26769967 | Activation of the DNA Damage Response by RNA Viruses |
| Q39227077 | An Epstein-Barr virus mutant produces immunogenic defective particles devoid of viral DNA. |
| Q36680086 | Cancer prevention in HIV-infected populations |
| Q52340211 | Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives. |
| Q27003831 | Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival |
| Q35130194 | Cytomegalovirus and Epstein-Barr virus in breast cancer |
| Q39455821 | DNA Oncogenic Virus-Induced Oxidative Stress, Genomic Damage, and Aberrant Epigenetic Alterations |
| Q26751349 | Diabetes, Epstein-Barr virus and extranodal natural killer/T-cell lymphoma in India: Unravelling the plausible nexus |
| Q64085282 | Down-regulation of intracellular reactive oxygen species attenuates P-glycoprotein-associated chemoresistance in Epstein-Barr virus-positive NK/T-cell lymphoma |
| Q34636601 | EBV-associated lymphomas in adults |
| Q33723664 | Epigenetic regulation of EBV persistence and oncogenesis |
| Q36204326 | Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma |
| Q38871275 | Epstein-Barr virus BZLF1 protein impairs accumulation of host DNA damage proteins at damage sites in response to DNA damage. |
| Q38854742 | Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression |
| Q40046633 | Epstein-Barr virus infection and nasopharyngeal carcinoma |
| Q31143601 | Genomic Instability: The Driving Force behind Refractory/Relapsing Hodgkin's Lymphoma |
| Q33743745 | Human papillomavirus type 16 E6* induces oxidative stress and DNA damage |
| Q35720026 | Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses |
| Q38107828 | Interplay between DNA tumor viruses and the host DNA damage response. |
| Q39400493 | LMP1 and Dynamic Progressive Telomere Dysfunction: A Major Culprit in EBV-Associated Hodgkin's Lymphoma |
| Q35539719 | LMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates. |
| Q40163621 | Limited nucleotide pools restrict Epstein-Barr virus-mediated B-cell immortalization |
| Q42206678 | Modelling the structure of full-length Epstein-Barr virus nuclear antigen 1. |
| Q26825783 | Modulation of DNA damage and repair pathways by human tumour viruses |
| Q57793552 | Nuclear lactate dehydrogenase A senses ROS to produce α-hydroxybutyrate for HPV-induced cervical tumor growth |
| Q28077167 | Oxidative Stress during HIV Infection: Mechanisms and Consequences |
| Q26752041 | Oxidative stress and age-related changes in T cells: is thalassemia a model of accelerated immune system aging? |
| Q26849641 | Pathogenesis of virus-associated human cancers: Epstein-Barr virus and hepatitis B virus as two examples |
| Q26852071 | Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus |
| Q40089376 | Regulation of Telomere Homeostasis during Epstein-Barr virus Infection and Immortalization. |
| Q40046642 | Take your PIKK: tumour viruses and DNA damage response pathways. |
| Q36497017 | Telomeres and viruses: common themes of genome maintenance. |
| Q48207441 | Telomeres: Implications for Cancer Development |
| Q34246710 | The DNA damage response in viral-induced cellular transformation |
| Q38166365 | The Epstein-Barr Virus EBNA1 Protein |
| Q38529622 | The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability. |
| Q39329214 | The role of metabolic reprogramming in γ-herpesvirus-associated oncogenesis. |
| Q39344275 | The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications. |
| Q47571734 | Viral Oncology: Molecular Biology and Pathogenesis |
Search more.